MUC-1 Peptide Vaccine
A cancer vaccine comprised of a synthetic peptide derived from the mucin 1 (MUC1) antigen with potential antineoplastic activity. Upon administration, MUC1 peptide vaccine may stimulate the host immune system to mount a cytotoxic T lymphocyte (CTL) response against tumor cells positive for the MUC1 antigen, resulting in decreased tumor growth. Overexpressed on many tumor cells, MUC1 antigen, a mammary-type apomucin, is a high-molecular-weight transmembrane glycoprotein.
Exact Synonyms
MUC-1 Peptide Vaccine
MUC1 Peptide Vaccine
class Information
code
C53290
Contributing_Source
CTRP
Display_Name
MUC-1 Peptide Vaccine
Has_Target
in_subset
Legacy Concept Name
MUC-1_Peptide_Vaccine
NCI_Drug_Dictionary_ID
458103
PDQ_Closed_Trial_Search_ID
458103
PDQ_Open_Trial_Search_ID
458103
Preferred_Name
MUC-1 Peptide Vaccine
Semantic_Type
- Amino Acid, Peptide, or Protein
- Pharmacologic Substance
UMLS_CUI
C1711297